Diagnostic wearable medical devices market size to increase by USD 7,333.3 million: Evolving Opportunities with AliveCor Inc and Alphabet Inc among others

NEW YORK, Feb. 3, 2023 /PRNewswire/ — Technavio report provides the key offerings of 15+ vendors of the diagnostic wearable medical devices market. For instance, one of the key vendors, AliveCor Inc offers medical wearable devices such as KardiaMobile. Similarly, another vendor, Alphabet Inc provides medical wearable devices such as Fitbit sense 2, Fitbit versa 4, and Fitbit charge 5. To know about all major vendor offerings, Download a PDF Sample Report.

Diagnostic wearable medical devices market size to increase by USD 7,333.3 million: Evolving Opportunities with AliveCor Inc and Alphabet Inc among others

Technavio has announced its latest market research report titled Global Diagnostic Wearable Medical Devices Market 2023-2027

The Diagnostic Wearable Medical Devices Market by Application, Device, and Geography – Forecast and Analysis 2023-2027 report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 15.2{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} and register an incremental growth of  USD 7,333.3 million during the forecast period. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market.

Regional Analysis

By region, the global diagnostic wearable medical devices market is segmented into North America, Europe, Asia, and the Rest of World (ROW). North America will account for 37{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of the market’s growth during the forecast period. The increase in the incidence of chronic diseases among people of all ages, the increased prevalence of heart and respiratory disorders, and a rise in the number of premature births are driving the growth of the regional market. For more insights, buy the report!

Market dynamics

The market is driven by factors such as the growing demand for early diagnosis and preventive medicine, the increasing prevalence of chronic diseases, and the increased need for cost-effective diagnosis. However, data privacy issues are hindering market growth.

Competitive analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share, among others. Request a Sample.

Market segmentation

  • By application, the market is segmented into home healthcare, sports and fitness, and remote patient monitoring. The home healthcare segment accounted for the largest share of the market during the forecast period.

  • By geography, the market is segmented into North America, Europe, Asia, and the Rest of World (ROW). North America held the largest share of the market in 2021.

Related Reports:

Echocardiography (ECG) Devices Market by End-user, Product and Geography – Forecast and Analysis 2023-2027: The echocardiography (ECG) devices market is estimated to grow at a CAGR of 5.7{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} between 2022 and 2027. The size of the market is forecast to increase by USD 4,102.12 million. The increased incidence of cardiac disorders is notably driving the market growth, although factors such as the high cost of ECG products and procedures may impede the market growth.

Breast Biopsy Devices Market by Product, End-user, Modality, and Geography – Forecast and Analysis 2023-2027: The breast biopsy devices market is estimated to grow at a CAGR of 10.95{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} between 2022 and 2027. The size of the market is forecast to increase by USD 721.64 million. The growing prevalence of breast cancer cases is notably driving the market growth, although factors such as the high cost of breast biopsy may impede the market growth.

Technavio’s library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our “Basic Plan” at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this diagnostic wearable medical devices market report?

  • CAGR of the market during the forecast period

  • Detailed information on factors that will drive the growth of the diagnostic wearable medical devices market between 2023 and 2027

  • Precise estimation of the size of the diagnostic wearable medical devices market and its contribution to the parent market

  • Accurate predictions about upcoming trends and changes in consumer behavior

  • Growth of the diagnostic wearable medical devices market across North America, Europe, Asia, and Rest of World (ROW)

  • A thorough analysis of the market’s competitive landscape and detailed information about vendors

  • Comprehensive analysis of factors that will challenge the growth of diagnostic wearable medical devices market vendors

Diagnostic Wearable Medical Devices Market Scope

Report Coverage

Details

Page number

173

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 15.2{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}

Market growth 2023-2027

USD 7333.3 million

Market structure

Fragmented

YoY growth 2022-2023 ({bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f})

14.54

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}

Key countries

US, Germany, UK, China, and Japan

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Activinsights Ltd., AliveCor Inc., Alphabet Inc., BTS Bioengineering Corp., Cleveland Medical Devices Inc., Draegerwerk AG and Co. KGaA, Garmin Ltd, Intelesens Ltd., Koninklijke Philips NV, Medtronic Plc, OMRON Corp., Polar Electro Oy, ResMed Inc., Smart Solutions Technologies SL, VitalConnect Inc., Wellue Health, and World Global Network

Market dynamics

Parent Market Analysis; Market growth inducers and obstacles; Fast-growing and slow-growing segment analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse for Technavio “Health Care” Research Reports

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Application

7 Market Segmentation by Device

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Trends

11 Vendor Landscape

12 Vendor Analysis

13 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Global Diagnostic Wearable Medical Devices Market 2023-2027

Global Diagnostic Wearable Medical Devices Market 2023-2027

Cision

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/diagnostic-wearable-medical-devices-market-size-to-increase-by-usd-7-333-3-million-evolving-opportunities-with-alivecor-inc-and-alphabet-inc-among-others—technavio-301737415.html

SOURCE Technavio

Medical student research opportunities with Leelabati Biswas | AMA Update Video

AMA Update addresses a assortment of health treatment subjects influencing the life of medical professionals, inhabitants, healthcare students and sufferers. From private practice and wellbeing method leaders to researchers and public wellness officers, listen to from the authorities in medicine on COVID-19, monkeypox, health-related instruction, advocacy concerns, burnout, vaccines and much more.


 

In today’s AMA Update, Leela Biswas, an MD/PhD applicant at Rutgers Robert Wood Johnson Health care College, is this year’s AMA Study Challenge winner, which will come with a $10,000 grand prize sponsored by Laurel Road. She discusses professional medical pupil research grants and funding, ideas for finding a mentor, and additional about her winning investigate: “Decoding Being pregnant Loss, Validating a Novel Genetic Biomarker of Inadequate Egg High quality.” AMA Chief Practical experience Officer Todd Unger hosts.

View 2022 AMA Investigate Obstacle finals.

Browse Leela’s “Validating a genetic biomarker tied to miscarriages” investigation submission.

Speaker

  • Leela Biswas, an MD/PhD applicant, Rutgers Robert Wood Johnson Medical School

Unger: Hi there and welcome to the AMA Update video and podcast. Currently, we are joined by Leela Biswas, an MD/PhD candidate at Rutgers Robert Wood Johnson Healthcare University, in New Brunswick, New Jersey, and also, this year’s winner of the AMA Research Challenge function, which I had the satisfaction of hosting, just a couple of days ago. We’re heading to talk to her about her study journey and what it feels like to be a winner of the $10,000 grand prize. I am Todd Unger, AMA’s main knowledge officer, in Chicago. Leela, welcome.

Biswas: Hi, Todd. How are you? Great to see you.

Unger: I’m wonderful. I bet you are emotion rather superior. It was type of a fantastic week for you. Huh?

Biswas: Yes, an fantastic 7 days, really thrilling.

Unger: Perfectly, congrats once again on winning the $10,000 grand prize for the AMA Analysis Challenge. That’s furnished by our friends at Laurel Street. Thank you, Laurel Highway. Just before we dive in, I thought it’d be pleasurable just to observe that second you won. How does it truly feel to be the winner of the 2022 AMA Exploration Problem with a grand prize of $10,000?

Biswas: I’m stunned. Oh my goodness, my heart is beating genuinely swiftly. Wow. I’m incredibly shocked. I was anticipating a whole lot of concerns and I was psyched for a adhere to-up discussion on the exploration, but this is genuinely fantastic news.

I am incredibly flattered, simply because the study from my colleagues, in both equally the semi-finals and the finals, was remarkable. I was in just an incomparable team of enjoyable clinicians and student researchers. So I experience quite fortunate to be selected as the winner. I’m incredibly flattered. Thank you so substantially.

Unger: That was truly exciting. That was a great reaction. As you know, successful the AMA Research Obstacle, it is really a major accomplishment.

There had been 1,200 entries for the party, which is a report. And then you were picked by an elite panel of judges—Dr. Kirsten Bibbins-Domingo, Dr. Sanjay Desai and Dr. Clyde Yancy—to acquire this year’s Investigate Problem. Did you imagine you were going to occur out on top of that?

Biswas: Very well, it was an amazing area of rivals, from the semifinalists all the way down to 5 incredible finalists, ranging in exploration from resuscitation devices to AI detection of pancreatic most cancers. It was totally spectacular. So I was amazed to be chosen, just simply because the subject was so stunning. If you have not watched it, check it out. It truly is incredible.

Unger: Now, you claimed, you’ve received an additional extensive volume of faculty and training. It sounded about 40 years that this cash is heading to arrive in helpful. Is that correct?

Biswas: Yeah. Yeah. So it really is an 8-yr system. So so lots of expenses related with that, and I know Laurel Highway is really familiar with that working experience for a whole lot of college students. And so this will be definitely beneficial in aiding to go that together and so I can become a health practitioner scientist. Get to residency, get to fellowship and then make it around the last hump. And hopefully, have a faculty situation and do some a lot more meaningful investigate that improvements affected individual care.

Unger: Nicely, just one detail you stated was, the explanation you entered the obstacle was to get diverse perspectives and feed-back that seriously crossed specialty. This is a multi-specialty party, of class. Notify us extra about that and why it was this sort of an significant motivator for you and piece of study in basic.

Biswas: Yeah. Medication is an interdisciplinary occupation by its pretty character. Just about every human being is designed up of so a lot of distinct organ methods, as we know from just the preclinical curriculum, and all of people keep on to interact for the rest of a person’s life. And as we go along, the medical treatment group is led by medical professionals from many, several, several different disciplines, and it can be crucial that we can all communicate to each and every other.

And the field that I’m in, it can be surely fertility and obstetrics, but it can be also precision medicine, and precision drugs crosses each individual self-control. So it was really important for me to see how other medical professionals and other fields thought about my investigation.

The way they think about their scientific complications is unique from the way a different health practitioner may and so those people views definitely enhance the type of research that we’re undertaking. The much more physicians can discuss to just about every other, willpower to discipline, the greater patient care is and the a lot more that we can do for people.

Unger: Now, just about every good piece of investigation begins with a genuinely good, exciting, crucial query. What had been you seeking to solve with this?

Biswas: Yeah. So ideal now, the only biomarker that we have for a woman’s egg top quality, how good her eggs are in terms of chromosomal abnormality, is maternal age. But there are clients who have weak high quality eggs at the exceptional age window. So right now, sufferers assume, late 20s, early 30s, great time to get expecting.

And for most folks, it is, but there are men and women who will not healthy that paradigm. And they consider to get pregnant for a calendar year, then they stop up in the IVF clinic. They go as a result of an IVF cycle and they discover out that, even while on paper clinically they look fantastic, their age is excellent, that 80{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}, 100{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f} of their embryos are chromosomally irregular and that is devastating. It is really so costly. It really is emotionally taxing.

And so we want to adjust that paradigm. We want to acquire a large action again, before people are striving to get pregnant and say, can we establish persons who are not going to do properly in advance? And then that data will make it possible for clinicians and doctors and the people to work jointly to style and design a care prepare that actually optimizes pregnancy results from the get go, relatively than hoping and failing and not understanding what’s heading on. We are empowering sufferers and medical professionals to make much more personalised selections.

Unger: Leela, the way that you just explained it is genuinely compelling, since I am certain that waiting around time, when somebody’s figuring out, this is not heading as planned, that is truly distressing. So what you might be stating is really meaningful and the science is what the judges truly circled in on. We reported it was pretty compelling. What was exclusive about your strategy in executing this function?

Biswas: It is devastating. You’re thoroughly appropriate, Todd, and that is why we had been psyched about this issue. We wanted to make modifications for people. And in conditions of the science, there were being a few of matters that have been truly unique about the way that we did this.

So this is an NIH-funded project, led by my PI, Karen Schindler, and our collaborator, Dr. Jinchuan Xing and they took a few of definitely exciting techniques in terms of planning the experiment. So 1 is we are concentrating on people who are clinically standard, clinically glance good, but have this puzzle of a dilemma. So like I reported, they’re coming into clinic and they appear to be entirely standard, but then items are not operating out soon after seeking for being pregnant.

And so by using a population that we you should not ordinarily assume of as owning a ailment in the very first location, we’re capable to essentially appear at men and women in a a lot more customized way and so that was genuinely special in this article. We’re truly digging into what would make me, me and what helps make you, you and how that influences our health care in standard and our health in the course of our lifespan.

And then a further thing was the experimental style. So right here, we took genomic or genetic data from people and then we introduced that into the laboratory. And we have been ready to do an successful screening using cells in a dish, but then we all know that cells in a dish usually are not people and they are not even full organisms.

So we ended up able to do that successful screening and tests of variants and cells in a dish and then deliver that again and exam it rigorously making use of a entire organism, so a full mouse design, which is the additional pricey piece.

So we were being in a position to do actually strong science, although being really efficient and smart about it. And I imagine that was sophisticated about the research and which is what the judges appreciated. And finally, it helps make it extra translational and much more capable to be rapidly translated into the clinic, and that’s what we are enthusiastic about.

Unger: What do you think would be the extended-expression influence here, if you could establish a marker like this? How is that going to modify matters going forward?

Biswas: Yeah. So what I imagine is that we will be equipped to determine and validate variants like this lengthy phrase.

I assume this is an identifiable genetic basis of a authentic phenotype and in the clinic, my hope that is when we’re equipped to absolutely translate all of this to the clinic, whether or not it’s this variant or other variants, that people effectively ahead of they are interested in conceiving would arrive in and get a genetic check, which is just a blood check, that would give medical professionals and sufferers perception into how a patient’s eggs are probably to carry out very long phrase. So it’s not just maternal age.

Maternal age is critical, but bringing in that genetic piece from the beginning, so that persons can program their reproductive upcoming. It is about empowering patients, empowering physicians with all of the information, so that they can make selections that in fact enhance the pregnancy outcomes from the get go. So early genetic testing, relatively than seeking and failing and then being devastated.

Unger: Now, it seems like you had great guidance from some wonderful mentors. What is your suggestions to other health-related learners out there who they really don’t know where by to commence? How do you get connected with mentors in this to support jumpstart your analysis profession?

Biswas: Yeah. It can be actually challenging and daunting, when you are in faculty and you want to get into investigation, and you just never know exactly where to start. So I believe a couple of things are at perform. So a single issue is be open to alternatives. Occasionally, you can get email messages or see a information report about a PI that’s seriously exciting to you.

Never be frightened to cold-e mail individuals and arrive at out. Deliver them your resume. Inform them why you might be fascinated and say, “Hey, I never have a great deal of experience, but I am enthusiastic to find out and keen to bounce into the lab or into your scientific study project. Is there any way that I could aid out?”

I assume just using options and then also becoming open to serendipity. So I have my excellent, astounding PI in the laboratory and she is my crucial study mentor, Dr. Karen Schindler. But then I also have other mentors that I have gained as a result of just likely by means of health-related faculty and becoming open up.

So, for illustration, I lately did a study course in Woods Gap, up in Massachusetts, at the storied maritime organic laboratories, which is amazing. And there, I got to fulfill yet another clinician scientist mentor, Dr. Elizabeth Taglauer, who’s been mentoring me in conditions of vocation planning and becoming a medical professional-scientist and moving by this process.

And so you have to be open up to all the diverse chances that are out there. Get options when they appear and just be enthusiastic. Be energized and when you get knocked down, received to stand again up and preserve attempting.

Unger: Very well, Leela, of course, analysis will not change out the way you assume it will all the time, and that get again up, dust on your own off and keep testing, that is actually crucial. Clearly, loads of issues in starting up a occupation as a medical doctor-scientist and the Research Obstacle is the way that AMA is really making an attempt to assistance individuals out there get that vocation commenced. Is there any other way that the AMA can enable learners like you get their analysis careers going?

Biswas: Yeah, completely. The AMA is nationally, and perhaps internationally, identified as the most strong health practitioner advocacy group in the nation. And in phrases of the advocacy, they can do for raising residency slots, so that we can produce a lot more medical professionals.

The additional medical professionals that we have in basic, the additional health practitioner-scientists we can have as perfectly. Every single physician has inquiries that they identify in the clinic, has curiosity and can do some form of study in some way, no matter whether it is simple investigation, translational study, medical study, smaller, huge, it will not make a difference. Just about every medical doctor is poised to go science and medication ahead for the betterment of clients.

In addition, advocating for more NIH funding. So funding from the Nationwide Institutes of Wellness is essential for performing clinical investigation. These forms of research are really costly, and we need to invest in both of those standard and medical study to maintain going drugs forward.

I feel individuals are definitely important, and then as a student, I imagine becoming a member of the AMA, connecting with other physicians, getting some of that professional growth abilities and doing things like the Research Challenge. Using options to develop your investigate, learn how to existing, attain suggestions other folks, other disciplines, so crucial, so impactful. So all those are points that the AMA is doing and can do in the long term as nicely.

Unger: Well, I hope we performed a portion in launching your clearly interesting vocation as a medical doctor-scientist. I just want to say congratulations yet again on your achievements and thank you once more to Laurel Road for sponsoring the $10,000 grand prize for a second year in a row.

I would just like to inspire every person out there, all you professional medical pupils, inhabitants, intercontinental healthcare graduates, interested and jumpstarting your investigate vocation, do what Leela did and make sure that you submit your investigate proposal for up coming year’s Exploration Challenge.

Also, if you want to see how it is really carried out perfectly, choose a glance at the Research Challenge, which is up in complete on AMA’s YouTube channel. You can see all of the displays, all the judging and see accurately how it goes. And everybody, thanks for signing up for us today. You can obtain all our films at ama-assn.org/podcasts. Many thanks for becoming a member of us currently and be sure to, acquire care.

Biswas: Thank you, Todd, and thank you to Laurel Highway and all of the viewers.


Disclaimer: The viewpoints expressed in this movie are people of the members and/or do not automatically mirror the sights and policies of the AMA.

Promotion of Healthy Diets by Governments Presents Lucrative Opportunities

Promotion of Healthy Diets by Governments Presents Lucrative Opportunities

Corporation Symbol

Worldwide Collagen Sector

Global Collagen Market

World Collagen Marketplace

Dublin, Nov. 11, 2022 (Globe NEWSWIRE) — The “Collagen Marketplace by Product Form (Gelatin, Hydrolyzed Collagen, and Indigenous Collagen), Supply (Bovine, Porcine, and Maritime & Poultry), Software (Dietary Products and solutions, Foodstuff & Beverages, and Pharmaceuticals), Kind and Region – World wide Forecast to 2026” report has been extra to ResearchAndMarkets.com’s supplying.

The collagen market is believed to be valued at USD 4.1 billion in 2021 and is projected to reach USD 5.3 billion by 2026, recording a CAGR of 5.4{bf0515afdcaddba073662ceb89fbb62b6b1bf123143c0e06b788e1946e8c353f}, in phrases of worth. The burgeoning acceptance of anti-aging products and solutions is operating in favor of the marketplace. In addition, increasing wellness difficulties among the the geriatric population affiliated with muscle soreness and growing old have to have using the product to meet nutritional deficiencies. Occupied lifestyles have pushed the food stuff manufacturing field to develop new merchandise that could meet the rise in desire from buyers, which, in turn, fuels the all round collagen market. Intercontinental trade of these items has obtained prominence with their escalating need, complemented by improved transportation amenities.

By resource, the bovine phase is projected to account for the most significant marketplace share in the market place throughout the forecast time period.

Based mostly on supply, the bovine phase is projected to account for the premier market share in the sector through the forecast period of time. Collagen from bovine is superior in protein information and large-water solubility and has very low molecular bodyweight. As a final result, manufacturers are growing its utilization in the food & beverage field to provide much more healthy items to their people. Presently, bovine collagen dietary supplements that are derived from cow hides are very available in outlets.

By kind, the dry phase is estimated to account for the major share.

The dry section of the collagen is dominating the market. Powdered collagens showcase excellent mixing homes, which is why it is significantly staying employed in a variety of foods purposes. These can be additional to most foodstuff apps, such as espresso, smoothies, dairy solutions, snacks, soups, sauces, and confectionery goods, amid other individuals. The agglomerated powder possesses various other positive aspects: no lump formation, dust-free of charge managing, clean flowability, regularity, no clogging, and fantastic storage potential.

By products kind, the gelatin section is forecasted to account for the greatest marketplace share.

Gelatin is widely utilized in foods to enhance elasticity, regularity, and security. Gelatin is employed to make gelatinous desserts, gummy candies, many yogurts, and some marshmallows. is also included to specific meats to avert them from drying out and giving them an beautiful glaze. By performing as a coagulant, gelatin can be utilized to precipitate impurities throughout manufacturing of wine, beer, cider, and juices. In dairy products and solutions, gelatin is generally extra to lower-fats dairy products and solutions to give the sensation of ingesting body fat.

By application, the nutritional products phase is expected to account for the most significant marketplace share in the course of the review interval.

Collagen is combined with other elements in several balanced items due to its a variety of chemical and dietary homes. Collagen peptides, due to their superior binding attributes, are applied as a partial glucose replacer in protein bars. Collagen is also eaten in powder sort, included to sizzling drinks, smoothies, or baked items, to provide added protein.

Market Dynamics

Motorists

  • Escalating Apps of Collagen in the Healthcare and Pharmaceutical Market

  • Maximize in the Demand from customers for Cosmetic Products Made up of Collagen

  • Increasing Apps of Collagen in the Food & Beverage Business

Restraints

Alternatives

Problems

Crucial Subjects Lined:

1 Introduction

2 Investigate Methodology

3 Govt Summary

4 Premium Insights

5 Industry Overview

6 Sector Traits

7 Collagen Industry, by Supply

8 Collagen Sector, by Form

9 Collagen Market, by Solution Form

10 Collagen Industry, by Software

11 Collagen Market, by Location

12 Aggressive Landscape

13 Business Profiles

14 Adjacent and Connected Markets

15 Appendix

Firms Talked about

  • Gelita AG (Germany)

  • Nitta Gelatin, Inc. (US)

  • Weishardt (France)

  • Darling Ingredients (US)

  • Nippi Inc. (Japan)

  • Vinh Hoan Company (Vietnam)

  • Junca Gelatines, S.L. (Spain)

  • Lapi Gelatine (Italy)

  • Gelnex (Brazil)

  • Very important Proteins (US)

  • Ewald-Gelatine (Germany)

  • Collagen Remedies (British isles)

  • Crescent Biotech (India)

  • Foodmate Co. Ltd. (China)

  • Suboneyo Chemicals Pharmaceutical P Ltd. (India)

  • BioCell Technologies (US)

  • Amicogen (South Korea)

  • Kayos (India)

  • Aspen Naturals (US)

  • Chaitanya Chemical substances (India)

For a lot more details about this report go to https://www.researchandmarkets.com/r/5eeal5

Attachment

Get in touch with: Make contact with: ResearchAndMarkets.com Laura Wooden,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Get in touch with 1-917-300-0470 For U.S./ CAN Toll Free of charge Call 1-800-526-8630 For GMT Business office Hrs Simply call +353-1-416-8900